MD1471F1 - Antibacterial and antifungal medicinal agent - Google Patents

Antibacterial and antifungal medicinal agent

Info

Publication number
MD1471F1
MD1471F1 MD000026A MD000026A MD1471F1 MD 1471 F1 MD1471 F1 MD 1471F1 MD 000026 A MD000026 A MD 000026A MD 000026 A MD000026 A MD 000026A MD 1471 F1 MD1471 F1 MD 1471F1
Authority
MD
Moldova
Prior art keywords
juglone
hydroxyacid
alcoholic solution
polybasic
polybasic organic
Prior art date
Application number
MD000026A
Other languages
Romanian (ro)
Inventor
Vasile Rusu
Grigore Timco
Igor Casian
Ana Casian
Zinaida Cheptanaru
Vladimir Valica
Vadim Gavriluta
Victor GHICAVAI
Viorel Prisacari
Original Assignee
Mixta Moldo Franco Romana Euro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mixta Moldo Franco Romana Euro filed Critical Mixta Moldo Franco Romana Euro
Priority to MD000026A priority Critical patent/MD1471F1/en
Publication of MD1471F1 publication Critical patent/MD1471F1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the pharmaceutics, in particular to the stable agents with fungicidal and bactericidal action at the internal application thereof. Summary of the invention consists in the fact that the juglone (5-hydroxy-1,4-naphthoquinone) alcoholic solution additionally contains pharmaceutically acceptable polybasic organic hydroxyacids, for example, citric, malic or tartaric acid with the following component ratio, mass %: juglone 0,18...0,22 polybasic organic hydroxyacid 0,20...1,50 ethyl alcohol the rest. The presence of the polybasic hydroxyacid into the alcoholic solution in the indicated contents ensures a higher stability in storage (1,5...2,0 years) with the maintenance of the pharmacologic activity of the agent finished form, notwithstanding the water used for dilution, owing to the capacity of the given acids type to strongly complex with the alkali-earth metals ions present into the undistilled water. Claims: 2
MD000026A 2000-01-14 2000-01-14 Antibacterial and antifungal medicinal agent MD1471F1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD000026A MD1471F1 (en) 2000-01-14 2000-01-14 Antibacterial and antifungal medicinal agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD000026A MD1471F1 (en) 2000-01-14 2000-01-14 Antibacterial and antifungal medicinal agent

Publications (1)

Publication Number Publication Date
MD1471F1 true MD1471F1 (en) 2000-05-31

Family

ID=19738461

Family Applications (1)

Application Number Title Priority Date Filing Date
MD000026A MD1471F1 (en) 2000-01-14 2000-01-14 Antibacterial and antifungal medicinal agent

Country Status (1)

Country Link
MD (1) MD1471F1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023142221A1 (en) * 2022-01-26 2023-08-03 上海交通大学 Disinfection product based on citric acid and natural naphthoquinone compound

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023142221A1 (en) * 2022-01-26 2023-08-03 上海交通大学 Disinfection product based on citric acid and natural naphthoquinone compound
CN116530515A (en) * 2022-01-26 2023-08-04 上海交通大学 Disinfection product based on citric acid and natural naphthoquinone compounds

Similar Documents

Publication Publication Date Title
US20030008851A1 (en) Acne treatment including dual-package system
EP2432506B1 (en) Hand sanitizer
ZA200501715B (en) Solution for ungual application
CA2484184A1 (en) Minoxidil foam formulation
US9357771B2 (en) Foaming sanitizing formulations and products including a quaternary ammonium compound
CO5271759A1 (en) FORMULATION IN SOLUTION CONTAINING A MIXTURE OF SOLVENTS
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
CN111093370A (en) Antimicrobial compositions
MD1471G2 (en) Antibacterial and antifungal medicinal agent
MD1471F1 (en) Antibacterial and antifungal medicinal agent
WO2003045326A3 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
GB2365770B (en) Antifungal ketoconazole composition for topical use
IT1254136B (en) ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, WITH ANTI-Fungal activity.
ATE333877T1 (en) AMLOPIDINE BEZYLATE TABLETS WITH IMPROVED STABILITY
WO2000067732A3 (en) Pharmaceutical composition, containing an antimycotic, polydocanol and salicylic acid
MD1779G2 (en) Dermatologic film-forming composition with juglone (variants)
EP1059292A3 (en) New adamantane derivative and aqueous disinfectant composition containing it
GB2275191A (en) Use of tolnaftate and tolciclate in treatment of skin disorder
WO2006105741B1 (en) Topical pharmaceutical formulation containing nimesulide
HUP9800235A2 (en) Process for producing topical pharmaceutical compositions for treating and preventing dermal infections
MD1918F1 (en) Stable dermatologic gel with juglone (variants)
RU2000113775A (en) PREPARATION AND TREATMENT OF ENDOMETRITIS
BG104682A (en) Liquid pharmaceutical formulation containing zotepine

Legal Events

Date Code Title Description
MM4A Patent for invention definitely lapsed due to non-payment of fees